Zyla Life Sciences US Inc. is recalling 3,792 bottles of Oxaydo (oxycodone HCl, USP) 7.5 mg tablets because the medication may be sub-potent, meaning it contains a lower concentration of the active ingredient than indicated on the label. This prescription pain medication was distributed nationwide in 100-count bottles. The recall is specifically for lot number 22W02 with an expiration date of January 31, 2025.
Patients taking sub-potent medication may not receive the full intended dose of oxycodone, which could lead to inadequate pain management. To date, no specific injuries or adverse health effects have been reported in connection with this recall.
You have 2 options:
Recall number D-0094-2024; quantity 3,792 bottles
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.